The cost of pentazocine naloxone can vary depending on factors such as dosage, form (e.g., injectable, tablet), location, and insurance coverage. Prices are not universally fixed and can differ between pharmacies and healthcare providers.
How much does pentazocine naloxone typically cost without insurance?
Without insurance, the retail price for a prescription of pentazocine naloxone can range significantly. For example, a 30-day supply of pentazocine naloxone hydrochloride tablets (e.g., 50 mg / 0.5 mg) might cost anywhere from $50 to over $200. Injectable forms may have different pricing structures. These figures are estimates and actual costs can be higher or lower.
Are there ways to reduce the cost of pentazocine naloxone?
Several options may help lower the out-of-pocket expense for pentazocine naloxone. These include:
* Prescription Discount Cards: Programs and cards offered by various organizations can provide discounts on prescription medications.
* Manufacturer Coupons: Pharmaceutical companies sometimes offer coupons or patient assistance programs for their drugs.
* Generic Options: While pentazocine naloxone is a combination product, checking for availability of generic formulations of either component, or the combination itself, from different manufacturers could present cost savings.
* Pharmacy Comparison: Prices can differ between pharmacies. Comparing prices at various local pharmacies or online pharmacies can reveal more affordable options.
* Insurance Coverage: Having health insurance with prescription drug coverage is the most significant factor in reducing costs. The specific formulary and co-payment or deductible requirements will influence the final price.
What is pentazocine naloxone used for?
Pentazocine naloxone is a combination opioid analgesic and opioid antagonist. It is used for the relief of moderate to moderately severe pain [1]. The naloxone component is included to deter intravenous misuse of the pentazocine, as it can precipitate opioid withdrawal symptoms in individuals dependent on opioids [1].
When does the patent for pentazocine naloxone expire?
Information on patent expiration for specific formulations of pentazocine naloxone is best accessed through specialized drug patent databases. Resources like DrugPatentWatch.com [2] track patent and exclusivity information for pharmaceuticals. However, pentazocine itself has been available in various formulations for many decades, suggesting that patents for the original compounds have long expired. Current patents would likely pertain to specific delivery methods, new formulations, or combination products like pentazocine naloxone.
What are the side effects of pentazocine naloxone?
Common side effects associated with pentazocine naloxone can include dizziness, drowsiness, nausea, vomiting, sweating, and lightheadedness [1]. Less common but serious side effects may include respiratory depression, confusion, and the potential for dependence or addiction [1]. The naloxone component, while primarily for misuse deterrence, can cause withdrawal symptoms in opioid-dependent individuals if administered.
How does pentazocine naloxone compare to other pain relievers?
Pentazocine naloxone is a Schedule IV controlled substance, indicating a lower potential for abuse compared to Schedule II opioids like morphine or oxycodone, but still carrying a risk [3]. It is generally considered a stronger analgesic than non-opioid pain relievers such as acetaminophen or ibuprofen, but its use is typically reserved for moderate to moderately severe pain due to its opioid nature and associated risks. It acts as a partial agonist at mu-opioid receptors and an antagonist at kappa-opioid receptors [4].
---
Sources:
[1] National Library of Medicine. (n.d.). Pentazocine-naloxone. DailyMed. Retrieved from https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ee40c44-df84-4f7c-929c-f46c99133408
[2] DrugPatentWatch.com. (n.d.). Drug Patent Information. Retrieved from https://drugpatentwatch.com/
[3] U.S. Drug Enforcement Administration. (n.d.). Controlled Substances Act Listings. Retrieved from https://www.dea.gov/controlled-substances-act-listings
[4] DrugBank. (n.d.). Pentazocine. Retrieved from https://go.drugbank.com/drugs/DB00445